Close Menu

NEW YORK – NantHealth said Thursday after the close of the market that it posted a marginal year-over-year increase in its third quarter revenues. 

For the three months ended Sept. 30, the Culver City, California-based company recorded revenues of $22.4 million, compared to $22.3 million in Q3 2018.

However, NantHealth said that it became cash flow-positive for the first time during the quarter. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.